This “Biotech In Digital Health Clothing” Has The Potential To Become A Powerful Drug Maker
Information collected through genetic testing business has the potential to become a powerful drug developer.
Stock Market
Millionaire-Maker Biotech Penny Stocks
“When it comes to investing in biotech penny stocks, there are some ways to dramatically increase your chances of success and to give yourself a good chance of becoming a millionaire or even a multimillionaire in the process.”
“Speculative But Promising”: A Newly IPO-ed Biotech With A Very Different Approach To Psychedelics
“New therapies derived from psychedelic compounds…are offering hope, not to mention a slew of opportunities for forward-thinking investors.”
3 Mid-Year Mid-Cap Biotech Picks
“All three picks can be volatile but very tradable and should be considered as long term holds with expectations for growth, positive clinical data or M&A.”
New Stocks To Watch In Tech, Biotech, Homebuilding & More
Tech companies involved in software, AI and e-commerce, and a medical device company that designs innovative injection technologies, are among the new stocks to watch.
A Trio Of Top Biotech Stock Picks
When it comes to the future of the biotech industry, the author of today’s article notes that “the aging population ensures that demand for new… Read More »A Trio Of Top Biotech Stock Picks
With A Potential Blockbuster Drug, And Ripe For Acquisition, This Biotech Stock Could Be A Big Winner
With a potential $5+ billion drug that could ultimately be used against dozens of diseases, the clinical-stage biotech company discussed in today’s article “is a ripe acquisition target, and when that acquisition comes, it will go for a steep price.”
After Experiencing Extreme Volatility This Month, Does This Biopharma Stock Have Any Upside Left?
Shares of the relatively unknown biopharmaceutical company discussed in today’s article have experienced extreme volatility this month, hitting their all-time low on June 2nd before proceeding to soar to their all-time high on June 10th.
An Outperforming Fund Ditched Novavax And Picked Up These 3 Biotech Stocks
Perceptive Life Sciences, a fund that has outperformed the market, sold all of its 1 million shares of Novavax in the first few months of 2021 and bought millions more shares of three biopharma/biotech stocks in the same period.
4 Oncology Stocks To Consider As Biotech Companies Escalate Their Fight Against Cancer
Examining four oncology stocks that could be smart picks right now.